Lipoprotein disorders and cardiovascular risk

Journal of Inherited Metabolic Disease

Volumn 26, Issue 2-3, 2003, Pages 267-287

  Genest, Jacques ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAMPESTANOL; CAMPESTEROL; CHOLESTANOL; CHYLOMICRON; ESTROGEN DERIVATIVE; FOLIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERMEDIATE DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; RETINOIC ACID DERIVATIVE; SITOSTANOL; SITOSTEROL; SPHINGOMYELIN; STEROID; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CLINICAL FEATURE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DYSLIPOPROTEINEMIA; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILIAL HYPERLIPEMIA; GENETIC DISORDER; GENETIC SCREENING; HEART MUSCLE ISCHEMIA; HUMAN; HYPERLIPOPROTEINEMIA; HYPERTRIGLYCERIDEMIA; LIMB ISCHEMIA; MONOGENIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHENOTYPE; REVIEW; SCREENING TEST;

EID: 0037483699     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024449603891     Document Type: Review

References (43)

1. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M (1996) Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271: 518-521.
2. Assmann G, Schulte H, von Eckardstein A, Huang Y (1996) High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 124: S11-20.
3. Berge KE, Tian H, Graf GA, et al (2000) Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290(5497): 1709-1711.
4. Brooks-Wilson A, Marcil M, Clee S, et al (1999) Mutations in the ATP binding cassette (ABC1) transporter gene in Tangier disease and familial HDL deficiency. Nature Genetics 22: 336-345.
5. Brown MS, Brown JL (1997) The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89: 331-340.
6. Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232: 34-47.
7. Danesh J, Collins R, Peto R (2000) Lipoprotein (a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 102: 1082-1085.
8. Davignon J, Genest J Jr (1998) Genetic disorders of lipoproteins. Endocrinol Clin North Am 27: 521-549.
9. de Man FH, de Beer F, van der Laarse A, Smelt AH, Havekes LM (1997) Lipolysis of very low density lipoproteins by heparan sulfate proteoglycan-bound lipoprotein lipase. Lipid Res 38(12): 2465-2472.
10. Emi M, Asaoka H, Matsumoto A, et al (1993) Structure, organization, and chromosomal mapping of the human macrophage scavenger receptor gene. J Biol Chem 268: 2120-2125.
11. Feoli-Fonseca JC, Levy E, Godard M, Lambert M (1998) Familial lipoprotein lipase deficiency in infancy: clinical, biochemical, and molecular study. J Pediatr 133: 417-423.
12. Genest J (2002) Genetics and prevention: a new look at HDL cholesterol. Cardiol Rev 10: 61-71
13. Genest J Jr, Martin-Munley SR, McNamara JR, et al (1992) Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 85: 2025-2033.
14. Genest JJ, Marcil M, Denis M, et al (1999) High-density lipoproteins in health and in disease. J Invest Med 47: 31-42.
15. Grundy SM (1997) Small LDL, atherogenic, dyslipidemia, and the metabolic syndrome. Circulation 95: 1-4.
16. Hansen PS, Defesche JC, Kastelein JJP, et al (1997) Phenotypic variation in patients heterozygous for familial defective apolipoprotein B (FDB) in three European countries. Arterioscler Thromb Vasc Biol 17: 741-747.
17. Havel RJ, Kane JP (1995) Structure and metabolism of plasma lipoproteins. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York: McGraw-Hill, 1841-1851.
18. Hiltunen TP, Luoma JS, Nikkari T, Yla-Herttuala S (1998) Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development. Circulation 97(11): 1079-1086.
19. Kuivenhoven JA, de Knijff P, Boer JM, et al (1997a) Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler Thromb Vasc Biol 17(3): 560-568.
20. Kuivenhoven JA, Pritchard H, Hill J, Frohlich J, Assmann G, Kastelein J (1997b) The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. J Lipid Res 38: 191-205.
21. Mahley RW, Huang Y, Rall SC Jr (1999) Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes. J Lipid Res 11: 1933-1949.
22. Marcil M, Brooks-Wilson A, Clee S, et al (1999) Familial HDL deficiency with defective cholesterol efflux is caused by mutations in cholesterol efflux regulatory protein (CERP/ABC1). Lancet 354: 1341-1346.
23. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomized placebo-controlled trial (2002). Heart Protection Study Collaborative Group. Lancet 360: 7-22.
24. Murray CJL, Lopez AD (1997) Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349: 1269-1276.
25. Murray I, Kohl J, Cianflone K (1999) Acylation-stimulating protein (ASP): structure-function determinants of cell surface binding and triacylglycerol synthetic activity. Biochem J 342(Pt 1): 41-48.
26. Narcisi TME, Shoulders CC, Chester SA, et al (1995) Mutations of the microsomal triglyceride-transfer-protein gene in abetalipoproteinemia. Am J Hum Genet 57: 1298-1310.
27. NCEP (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adults Treatment Panel III) (2001). JAMA 285: 2486-2497.
28. O'Connell B, Genest J Jr (2001) High density lipoproteins and endothelial function. Circulation 104: 1978-1983.
29. Oram JF (2000) Tangier disease and ABCA1. Biochim Biophys Acta 1529: 321-330.
30. Pajukanta P, Nuotio I, Terwilliger JD, et al (1998) Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23. Nature Genetics 18: 369-373.
31. Ridker P, Genest J Jr, Libby P (2000) Plasma lipids and lipoproteins and cardiovascular diseases. In: Libby P, Braunwald E eds. Braunwald's Heart Disease. New York: Saunders; 1010-1039.
32. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340(2): 115-126.
33. Santamarina-Fojo S (1998) The familial chylomicronemia syndrome. Endocrinol Metab Clin North Am 27: 551-567.
34. Segrest JP, Jones MK, Klon AE, et al (1999) A detailed molecular belt model for apolipoprotein A-I in discoidal high density lipoprotein. J Biol Chem 274(45): 31755-31758.
35. Sirtori CR, Calabresi L, Franceschini G, et al (2001) Cardiovascular status of carriers of the apolipoprotein A-I milano. The Limone sul Garda study. Circulation 103: 1949-1954.
36. Sorci-Thomas MG, Thomas MJ (2002) The effects of altered apolipoprotein A-I structure on plasma HDL concentration. Trends Cardiovasc Med 12(3): 121-128.
37. Vance DE, Van den Bosch H (2000) Cholesterol in the year 2000. Biochim Biophys Acta 1529: 1-8.
38. Viana MB, Giugliani R, Leite VHR, et al (1990) Very low levels of high density lipoprotein cholesterol in four sibs of a family with non-neuropathic Niemann-Pick disease and sea-blue histiocytosis. J Med Genet 27: 499-504.
39. Weinstock PH, Bisgaier CL, Aalto-Setala K, et al (1995) Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice: mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. J Clin Invest 96: 2555-2568.
40. Wilson DJ, Gahan M, Haddad L, et al (1998) A World Wide Web site for low-density lipoprotein receptor gene mutations in familial hypercholesterolemia: sequence-based, tabular, and direct submission data handling. Am J Cardiol 81: 1509-1511.
41. Wilson PW (1990) High-density lipoprotein, low-density lipoprotein and coronary artery disease Am J Cardiol 66(6): 7A-10A.
42. Yusuf S, Reddy S, Ounpuu O, Anand S (2001) Global burden of cardiovascular diseases. Circulation 104: 2746-2753.
43. Zhang SH, Reddick RL, Piedrahita JA, Maeda N (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258: 468-471.